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Vitamin D supplementation and acute 
respiratory tract infections
Acute respiratory tract infections (ARTIs) are responsible for 10% 
of visits to doctors in the USA and important causes of morbidity 
and mortality globally. Observational studies report consistent 
independent associations between low serum vitamin D levels and 
susceptibility to ARTI. A systematic review and meta-analysis from 
randomised controlled trials[1] published recently in the BMJ suggests 
that vitamin D supplementation is safe and protects against ARTI, the 
effect being particularly marked in those who were very deficient in 
the vitamin. However, a linked editorial[2] questions the validity of 
the data, saying that clinical practice should probably not be changed 
– yet. The authors point out that the primary result is a reduction 
from 42% to 40% in the proportion of participants experiencing at 
least one ARTI. Also, the definition of ARTI varied between studies, 
consisting of a mixture of diverse conditions such as acute otitis 
media, laboratory-confirmed influenza, self-reported colds or chest 
infections and radiograph-confirmed pneumonia.
The jury is still out.
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Anti-clotting drugs linked to bleeding 
near brain
A large Danish study has found that antithrombotic drug use, 
particularly use of a vitamin K antagonist, increases the risk of subdural 
haematoma. Researchers identified 10  000 patients with a first-ever 
subdural haematoma from 2000 to 2015, who were matched to more 
than 400 000 people from the general population. Among those with 
a subdural haematoma, 47% were taking antithrombotic medication.
The highest odds of subdural haematoma were associated with 
using a vitamin K antagonist such as warfarin. Low-dose aspirin was 
associated with a slightly increased risk of subdural haematoma, while 
clopidogrel and a direct oral anticoagulant were associated with a 
moderately higher risk. The highest risk was found in concurrent use of 
clopidogrel and a vitamin K antagonist. Overall, women were at higher 
risk than men with all antithromobotic drugs.
This study adds to the complexity of the risk-benefit equation of 
antithrombotic drug use.
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Ask two simple questions to predict 
depression in the elderly
Complex screening tools are no more effective than asking two 
simple questions to diagnose depression in older people, according 
to a review of clinical studies. The prevalence of depression in older 
people is 10 - 20%. Early detection and treatment will improve 
prognosis, but traditional screening is difficult because many somatic 
symptoms such as weight loss and disturbed sleep are common 
physical problems associated with ageing.
Researchers identified 133 studies evaluating 16 diagnostic tools 
in a total of 46 651 patients aged 60 - 87 years. Most studies used the 
Geriatric Depression Scale, but six used the Two Question Screen 
asking about symptoms in the past month: ‘Have you been troubled 
by feeling down, depressed or hopeless?’, and ‘Have you experienced 
little interest or pleasure in doing things?’. The results, reported in the 
British Journal of Psychiatry, showed that the Two Question Screen 
diagnosed depression as effectively as other screening instruments.
Tsoi KKF, Chan JYC, Hirae HW, et al. Comparison of diagnostic performance of Two-Question Screen and 
15 depression screening instruments for older adults: Systematic review and meta-analysis. Br J Psychiatry 
2017, bjp.bp.116.186932. https://doi.org/10.1192/bjp.bp.116.186932
Widespread use of pneumococcal 
conjugate vaccine in low- and middle-
income countries safe
This study, recently published in Lancet Global Health, shows that the 
local introduction in 2011 of the 13-valent pneumococcal conjugate 
vaccine (PCV13) using a 2 + 1 schedule is safe and effective in both 
HIV-infected and HIV-uninfected children.
PCV13 was designed to include disease-causing serotypes that 
are important in low- and middle-income countries. In this study, 
cases of invasive pneumococcal disease in children aged ≤5 years 
were identified through national laboratory-based surveillance 
and isolates were stereotyped. Age-matched, HIV status-matched 
in-hospital controls were sought for every case, aiming for four 
controls for every HIV-uninfected case and six controls for every 
HIV infection. Between January 2012 and December 2014, children 
aged ≥16 weeks were enrolled: 240 were cases not infected with 
HIV, 75 were cases with HIV infection, 1  118 were controls not 
infected with HIV, and 283 were controls with HIV infection. The 
effectiveness of two or more doses of PCV13 against PCV13-serotype 
invasive pneumococcal disease was 85% among 11 case-control sets 
of children not infected with HIV and 91% among three case-control 
sets of children with HIV infection. PCV13 effectiveness among 
26  case-control sets of children not infected with HIV was 52% 
against all-serotype invasive pneumococcal disease and 94% (44 - 
100%) for serotype 19A. Vaccine effectiveness against PCV7-serotype 
invasive pneumococcal disease was 87% in children exposed to HIV 
but uninfected and 90% (53 - 98%) in malnourished children not 
infected with HIV.
The results indicate that PVC13 in a 2 + 1 schedule is effective for 
preventing vaccine-type pneumococcal infections in young children 
not infected with HIV, including those who are malnourished or have 
been exposed to HIV. These findings support the recommendation 
for widespread use of pneumococcal conjugate vaccine in low- and 
middle-income countries.
Cohen C, von Mollendord C, de Gouveia L, et al. for the South African IPD Case-Control Study Group. 
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease 
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Increasing daily water consumption 
does not influence weight loss in 
adolescents
There is little evidence to support the common recommendation of 
increased water consumption, usually to eight cups a day, as part of a 
weight-reducing diet. A study recently published in JAMA Pediatrics 
suggests that increased water consumption has no effect on body 
weight among overweight adolescents.
The authors compared two standardised weight-loss diets among 
adolescents with overweight or obesity, randomised to receive similar 
weight-reducing interventions, but with one group receiving advice to 
increase their water intake to eight cups daily and the control group 
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to drink as normal. The interventions included dietary counselling, 
daily text messages and a cookbook with health guides. The water 
group received well-defined messages about water consumption 
through counselling and text messages, a water bottle and a water 
pitcher with filters.
All 38 participants completed the study, with both groups reporting 
drinking about two cups of water a day at baseline. Self-reported 
change in water intake at 6 months was greater in the water group 
than in the control group. However, there was no difference in body 
mass index at 6 months between the water group and the control 
group.
Wong JMW, Ebbling CB, Robinson L, et al. Effects of advice to drink 8 cups of water per day in adolescents 
with overweight or obesity: A randomized clinical trial. JAMA Pediatr 2017 (published online 6 March 
2017). https://doi.org/10.1001/jamapediatrics.2017.0012
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